Company Title


Temeoo is revolutionizing the field of ophthalmology with its cutting-edge AI software, specifically designed for automatic eye illness detection. Since its introduction in France in 2020, the software has demonstrated its efficacy and reliability in visual screening. It stands out for its user-friendly design, robust performance, and speedy operation, making it an indispensable tool in the medical community. Temeoo’s innovative approach has supported over 100 users, including healthcare professionals, and has conducted screenings for more than 150,000 patients, marking a significant milestone in automated medical diagnostics.